$PMCB Just an FYI. This company was paid $30,000 and given 500,000 shares of Immudyne to write about Immudyne. It mentions the potential of PMCB twice in the cannabinoid arena.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.